0001104659-17-043682.txt : 20170705
0001104659-17-043682.hdr.sgml : 20170705
20170705201511
ACCESSION NUMBER: 0001104659-17-043682
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170630
FILED AS OF DATE: 20170705
DATE AS OF CHANGE: 20170705
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nabriva Therapeutics Plc
CENTRAL INDEX KEY: 0001703287
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 56 FITZWILLIAM SQUARE
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: 6108166640
MAIL ADDRESS:
STREET 1: 1000 CONTINENTAL DRIVE
STREET 2: SUITE 600
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
FORMER COMPANY:
FORMER CONFORMED NAME: Nabriva Plc
DATE OF NAME CHANGE: 20170407
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Crotty Robert
CENTRAL INDEX KEY: 0001600253
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38132
FILM NUMBER: 17950577
MAIL ADDRESS:
STREET 1: 1301 2ND AVE
CITY: SEATTLE
STATE: WA
ZIP: 98101
4
1
a4.xml
4
X0306
4
2017-06-30
0
0001703287
Nabriva Therapeutics Plc
NBRV
0001600253
Crotty Robert
1000 CONTINENTAL DRIVE
SUITE 600
KING OF PRUSSIA
PA
19406
0
1
0
0
General Counsel & Corp Secreta
Stock Option
2017-06-30
4
A
0
90000
0.00
A
2027-06-30
Ordinary Shares
90000
90000
D
The exercise price is $10.48 per share.
This option was granted on June 30, 2017. Vesting will begin on June 30, 2017 and end on June 30, 2021. Twenty-five percent (25%) of the option will vest on June 30, 2018, and the remaining seventy-five percent (75%) will vest on a monthly pro-rata basis over the remaining vesting period.
/s/ Robert Crotty
2017-07-05